Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer ...
Introduction Pancreatic cancer is one of the most aggressive malignant tumors, with a 5-year survival rate of approximately 10%.1,2, Surgery excision is the common approach to eradicate pancreatic cancer, but it is necessary to combine this with …